
Keywords: BCH, 2-amino-2-norbornanecarboxylic acid; BSV, between subject variability; cGI, GI concentration; CL, systemic clearance; F, oral bioavailability; Fmax, maximum oral bioavailability; GI, gastrointestinal; GOF, goodness-of-fit; IV, intravenous; Km, Michae